PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): phallcon study

Bibliographic Details
Main Authors:	Jabbour, E., Martinelli, G., Vignetti, M., Kantarjian, Hagop M., Gómez Almaguer, David, Minami, Y., Dombret, H., Hennessy, M., Vorog, A., Wang, B., Ribera, J. M.
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2022
Subjects:	RC Medicina Interna, Psiquiatría, Neurología
Online Access:	http://eprints.uanl.mx/23831/1/23831.pdf

Internet